Usefulness of baseline activated clotting time-guided heparin administration in reducing bleeding events during transfemoral transcatheter aortic valve implantation

JACC: Cardiovascular Interventions

Volumn 7, Issue 2, 2014, Pages 140-151

  Bernelli, Chiara ^a   Chieffo, Alaide ^a   Montorfano, Matteo ^a   Maisano, Francesco ^a   Giustino, Gennaro ^a   Buchanan, Gill Louise ^a   Chan, Jaclyn ^a   Costopoulos, Charis ^a   Latib, Azeem ^a   Figini, Filippo ^a   De Meo, Ermelinda ^a   Giannini, Francesco ^a   Covello, Remo Daniel ^a   Gerli, Chiara ^a   Franco, Annalisa ^a   Agricola, Eustachio ^a   Spagnolo, Pietro ^a   Cioni, Micaela ^a   Alfieri, Ottavio ^a   Camici, Paolo Guido ^a   Colombo, Antonio ^a   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

activated clotting time; aortic stenosis; bleeding; transcatheter aortic valve implantation

Indexed keywords

ACTIVATED CLOTTING TIME; AORTIC STENOSIS; BLEEDING; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; AORTIC VALVE STENOSIS; BLOOD COAGULATION; BODY WEIGHT; CARDIAC CATHETERIZATION; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMORAL ARTERY; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HEPARIN; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WHOLE BLOOD COAGULATION TIME;

EID: 84894359249     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.10.016     Document Type: Article

References (18)

1. M.B. Leon, C.R. Smith, M. Mack for the PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
2. S.K. Kodali, M.R. Williams, and C.R. Smith et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
3. M.B. Leon, N. Piazza, and E. Nikolsky et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269
4. P. Généreux, S.J. Head, and N.M. Van Mieghem et al. Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies J Am Coll Cardiol 59 2012 2317 2326
5. D. Tchetche, R.M. Van der Boon, and N. Dumonteil et al. Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative Am Heart J 164 2012 402 409
6. A. Vincentelli, S. Susen, and T. Le Tourneau et al. Acquired von Willebrand syndrome in aortic stenosis N Engl J Med 349 2003 343 349
7. D.R. Holmes Jr., M.J. Mack, and S. Kaul et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement J Am Coll Cardiol 59 2012 1200 1254
8. E.M. Davis, S.K. Friedman, and T.M. Baker A review of antithrombotic therapy for transcatheter aortic valve replacement Postgrad Med 125 2013 59 72
9. C. Godino, F. Maisano, and M. Montorfano et al. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience J Am Coll Cardiol Intv 3 2010 1110 1121
10. G.L. Buchanan, A. Chieffo, and M. Montorfano et al. The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN and Medtronic CoreValve ReValving System devices: the Milan registry EuroIntervention 7 2011 556 563
11. A.S. Sharp, I. Michev, and F. Maisano et al. A new technique for vascular access management in transcatheter aortic valve implantation Catheter Cardiovasc Interv 75 2010 784 793
12. H. Curran, A. Chieffo, and G.L. Buchanan et al. A comparison of the femoral and radial crossover techniques for vascular access management in transcatheter aortic valve implantation: the Milan experience Catheter Cardiovasc Interv 83 2014 156 161
13. F. Figini, A. Latib, and F. Maisano et al. Managing patients with an indication for anticoagulant therapy after transcatheter aortic valve implantation Am J Cardiol 111 2013 237 242
14. A.P. Kappetein, S.J. Head, and P. Généreux et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document J Am Coll Cardiol 60 2012 1438 1454
15. J. Rodés-Cabau, H.L. Dauerman, and M.G. Cohen et al. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events J Am Coll Cardiol 62 2013 2349 2359
16. C.E. Ruiz Optimizing transcatheter aortic valve sizing and minimizing vascular complications J Am Coll Cardiol 59 2012 128 129
17. A. Chieffo, G. Melzi, and R. Rogacka et al. Safety and feasibility of bivalirudin with either Cypher and Taxus drug-eluting stent during percutaneous coronary intervention EuroIntervention 1 2005 70 74
18. D.R. Lynch Jr., D. Dantzler, M. Robbins, and D. Zhao Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation J Thromb Thrombolysis 35 2013 476 482